In a footnote to the official chart, Equibase will recognize both Miss Inclusive and Eighth Wonder as the winners of the 2016 Parx Oaks.
The California Horse Racing Board unanimously approved a measure to allow races to be run with medication-based eligibility conditions during its regularly scheduled monthly meeting Feb. 23 at Santa Anita Park.
An attorney for Ramon Preciado said the trainer does not plan to appeal three recent decisions to revoke his license by the stewards at Parx Racing as well as the Pennsylvania Horse Racing Commission.
A rules committee for horse racing's umbrella group of regulators, the Association of Racing Commissioners, failed to advance an industry-supported recommendation on expanded out-of-competition testing at its meeting July 14 in Seattle.
Regulatory body altered verbiage to move into line with court ruling, but issue currently only concerns Quarter Horse racing.
Horses who test positive for some substances in New Mexico effectively will be suspended for at least 60 days through use of the state’s stewards’ list.
John Servis, trainer of Kentucky Oaks (gr. I) winner Cathryn Sophia, is questioning three clenbuterol positives in his horses in April and May at Parx Racing, including one for a 3-year-old filly he said had never been administered the medication.
While Pennsylvania gets its new horse racing regulator in place, multiple graded stakes-winning trainer Ramon Preciado, who is accused of six clenbuterol positives in April and May at Parx Racing, continues to win races.
The New Mexico Racing Commission immediately will begin enhanced out-of-competition testing at SunRay Park in Farmington as the state regulator launches an enhanced effort to halt cheating.
Los Alamitos Race Course intends on running the next edition of the Los Alamitos Derby (gr. II) during its September meet, a track official said during a California Horse Racing Board meeting March 24.
Racing Medication and Testing Consortium executive director Dionne Benson said as regulators look at new, enhanced recommendations on out-of-competition testing, they're going to find policies that will work for the industry.
The Los Angeles Superior Court determined March 10 that Los Alamitos Race Course house rules on clenbuterol and albuterol testing in Quarter Horse races violated state laws and that the CHRB should not have allowed the rules.
An examination of horses trained by Kirk Ziadie involved in 18 clenbuterol positives in Florida in 2012 and 2013, points to the negative impact on horsemen who compete against a trainer breaking the rules.
The Delaware Thoroughbred Racing Commission Jan. 13 upheld a decision by its board of stewards to suspend trainer Ramon Preciado 21 days and fine him $1,500 for a pair of clenbuterol positives last summer.
A Florida administrative law judge has recommended South Florida-based trainer Kirk Ziadie have his racing license suspended for six years and be fined $18,000 for repeated clenbuterol violations in 2012, 2013, and 2014.
According to the California Horse Racing Board, there were only four Class 1, 2, or 3 medication violations in the state during the 2014-2015 fiscal year, the lowest number in at least 40 years.
Horsemen's representatives told the Ohio Horse Racing Commission March 30 that equine medication rules, which the commission is reviewing, should be breed-specific in nature.
California racing officials have identified a connection in the sudden death of six horses with trace amounts of anticoagulant rodenticide in their systems, the state horse racing board was told Dec. 18.
The Association of Racing Commissioners International has asked that the industry's Racing Medication and Testing Consortium be merged into a new RCI scientific advisory board.
In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
A horsemen's meeting on upcoming equine medication changes in Kentucky revealed some interesting information: The four months of racing at Turfway Park are the "cleanest" in the state according to drug-testing results.
Kentucky horsemen March 14 were given an overview of impending equine medication changes and also provided with a few tips to avoid headaches when the new regulations take effect later in the spring.
New York racing regulators raised the prospects of imposing new transparency standards on stewards, including possibly publicly releasing videos that are used by officials in decisions affecting the outcome of a race.
According to the Albuquerque Journal, New Mexico is the most recent state to have its racing commission approve uniform medication rules.
- By Frank Angst
Clenbuterol is a hot topic as industry takes steps toward uniform medication rules. watch video
Controversial Clenbuterol: This drug is a hot topic as industry takes steps toward uniform medication rules. Read the full feature in the February 15, 2014 issue of The Blood-Horse.
The Kentucky Horse Racing Commission on Dec. 11 approved changes to its withdrawal time guidelines for all racing breeds in line with the national uniform medication rules.
Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.
The Kentucky Equine Drug Research Council, on a 4-2 vote Dec. 3, recommended the Kentucky Horse Racing Commission adopt the national uniform medication rules for Thoroughbred racing.
A pair of position papers released by the Racing Medication and Testing Consortium find no physiologic difference in various racing breeds to justify changes to its regulatory thresholds for clenbuterol and corticosteroids.
Kentucky-based trainer Kellyn Gorder has been suspended 20 days and fined $500 by stewards after a horse he trained tested positive for the bronchodilator clenbuterol following a victory Aug. 10 at Ellis Park.
Trainer Jane Cibelli will serve a 60-day suspension and face sanctions from Tampa Bay Downs following the conclusion of an investigation by a Florida regulator.
- By Tom LaMarra
An official with the RMTC said confidentiality agreements used when the organization considers research to set thresholds and withdrawal times for medications are necessary because of scientific factors.
Scientific and regulatory advisers to the National Horsemen's Benevolent and Protective Association July 13 expressed concerns over the proposed withdrawal time and testing level for the bronchodilator clenbuterol.
Oft-sanctioned owner/trainer Scooter Davis and trainer Doug Shanyfelt have been banned from Charles Town Races and the West Virginia Racing Commission is reviewing evidence against both horsemen.
With regulators and industry groups leading the charge, many horse racing stakeholders believe sweeping medication reform could become a reality in early 2013.
New York racing regulators have amended rules, originally set to take effect Dec. 12, affecting the use of Clenbuterol and DempMedrol on Thoroughbred racehorses.
The Racing Medication and Testing Consortium board of directors has approved thresholds and withdrawal guidelines for six medications that have been identified as having therapeutic purposes.
The use of racehorse medications and importance of owner education were among the topics discussed among trainers Kellyn Gorder, Tom Proctor, and Phil Sims at the Welfare and Safety of the Racehorse Summit at Keeneland.
Prodded by a rash of equine deaths at Aqueduct Racetrack last winter, the New York State Racing and Wagering Board Oct. 11 imposed what officials promised will be the first round of rules intended to make for safer racing.
Quarter Horse trainer Adan Farias, arrested last month by federal authorities on money laundering charges involving a notorious Mexican drug cartel, has had his license revoked for two years by the CHRB in an unrelated case.
The bronchodilator clenbuterol, possibly being misused for its anabolic steroid properties, will be severely curtailed for the next year at all California racetracks.
The board of directors of the Jockeys' Guild has voted to adopt 10 policy statements concerning race day medications and safety concerns.
The California Horse Racing Board gave final approval April 26 to a rule change that eliminates "jail time" for most horses that are claimed.
The use and possible abuse of therapeutic medications will be dominating the discussions throughout the 78th annual Conference on Racing and Wagering Integrity underway in Oklahoma City April 25.
At its April 23 meeting the Racing Medication and Testing Consortium board of directors approved an agreement with The Jockey Club to engage the full-time services of Jamie Haydon as RMTC interim executive director.
The New York Thoroughbred Horsemen's Association April 13 announced a plan to reform medication policies in Thoroughbred racing that it believes addresses many of the issues that have brought criticism to the sport.
The CHRB Medication and Track Safety Committee will conduct a public meeting April 11, for discussion and action on a number of proposals relating to the safety of racehorses and the integrity of racing.
The New Mexico Racing Commission has suspended the use of clenbuterol for Thoroughbred and Quarter Horse racing, effective April 20.
The trainer of Ledge's Monarchos, fourth-place finisher in the Dec. 19, 2009 Gowell Stakes at Turfway Park, has been suspended 30 days after the 2-year-old filly tested positive for the prohibited substance Clenbuterol.
Most Popular Stories
- Del Mar Addressing Safety, Field Size Concerns
- Maryland Horse of the Year Ben's Cat Dies
- TVG Plans Special Coverage, Events at Saratoga
- Arrogate Begins Del Mar Journey in San Diego Handicap
- Remembering Ben's Cat
- Look Back: Shuvee Completes a Filly Triple Crown
- Leatherbury, Maryland Racing Mourn Ben's Cat
- Dickinson, Lady Eli to Meet Again in Diana
- Direct Dial, Admiral Jimmy Vie Again in Sanford
- Biancone Moves Closer to Kentucky Reinstatement